Impact of Ruxolitinib Interactions on JAK2 JH1 Domain Dynamics
用户qgRSP4os3S6M
15天前
36
10
已完结
1. 系统已在2025-09-26 15:45:12对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
HN Vu, R Radjasandirane, J Diharce…
International Journal of …, 2025
mdpi.com
… Ruxolitinib is a JAK inhibitor recently approved by the FDA/EMA and effective in relieving symptoms in patients with MPN. Ruxolitinib binds … the inhibitory effect of Ruxolitinib on the JH1 …